Related Experiment Video
Updated: Aug 18, 2026

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
Published on: October 17, 2025
[Vinflunine: a new anti-cancer fluorinated agent derived from Vinca-alkaloids]
J C Jacquesy1, M P Jouannetaud
1UMR 6514 Synthèse et réactivité des substances naturelles, 40, avenue du Recteur Pineau, F 86022 Poitiers, France.
Abstract:
Reaction in superacid HF-SbF5 in the presence of CCl4 of vinorelbine yields (4'R)-20',20'difluoro-3',4'dihydrovinorelbine (vinflunine), whereas vinblastine or anhydrovinblastine give the difluoro analog. The reaction implies a 20' chloro derivative as intermediate which undergoes hydrid abstraction at C20' followed by halogen exchange. Vinflunine is presently in phase III experimentation for treatment of bladder cancer and non small lung cancer.
Related Concept Videos
Drugs that Destabilize Microtubules
Inhibitors of Viral Protein Synthesis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Antiviral Nucleoside Inhibitors